AI-generated summary
This randomized controlled trial of 30 patients with shoulder myofascial pain syndrome compared intravenous laser therapy and percutaneous low level laser with placebo laser, with all groups receiving exercise, posture training and nortriptyline. The authors report that both laser groups had reduced pain-related disability and improved quality of life versus control, with no side effects, and that intravenous laser was not significantly better than percutaneous laser.
- Participants
- 30
- Who or what was studied
- Patients with shoulder myofascial pain syndrome
- Limits stated in the abstract
- The abstract reports a small sample of 30 patients divided into three groups, and does not report wavelengths or dosimetry.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Control group, Randomized controlled trial, Adverse event. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.